Drug approvals speed up by 20% under new FDA leadership by Q1 2027

Market overview

Regardless of Makary's fate, the FDA enacts policies under new leadership that accelerate drug approvals by reducing clinical trial burdens or streamlining review processes for priority drugs.

regulatory prediction market

Implied probability (Yes)

55%

Closes

2027-12-31

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• Senate blocks OMB grant rule by December 2026 — 72% Yes
• Biden administration approves ICE detention project within 6 months — 40% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →